Genitourinary syndrome of menopause. Genitourinary syndrome of menopause
Conditions
Interventions
Intervention group: Use of the vaginal cream nightly for six weeks, followed by every other night for the subsequent two weeks, at a dose of one-fifth of an applicator (1 g) per night..
Sponsors
Gonabad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age between 45 and 65 years At least one year elapsed since the onset of menopause Provision of informed consent to participate in the study Married No history of pelvic surgery (based on participant self-report) No use of estrogen-containing medications Absence of vaginal bleeding No history of pelvic or whole-body radiotherapy or chemotherapy No history of cancer No sexual problems in the relationship with the spouse (based on participant self-report) No vaginal infections (based on participant self-report and assessment of clinical symptoms of vaginitis) Presence of at least two symptoms listed in the descriptive vaginal mucous assessment table (color, rugae, petechiae, elasticity, dryness) Absence of diabetes mellitus (based on participant self-report) A score of 28 or lower on the Female Sexual Function Index (FSFI)
Exclusion criteria
Exclusion criteria: Hypersensitivity or allergic reaction to the cumin vaginal cream during the study Use of any medication affecting sexual function during the study period-initiation of hormonal therapy during the study Occurrence stressful life events in the participant or her spouse during the study period
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life. Timepoint: Assessment of quality of life at baseline (before the intervention) and at week eight after starting the vaginal cream. Method of measurement: Menopause-Specific Quality of Life Questionnaire (MENQOL). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarjes bahri
Gonabad University of Medical Sciences
Outcome results
None listed